Medicare Enrolled
Dr. Lawrence Lee, M.D.
Student in an Organized Health Care Education/Training Program · Pottstown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Lawrence Lee is a student in an organized health care education/training program specialist in Pottstown, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 6,186 Medicare services across 1,681 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $18,726 from 59 pharmaceutical and/or device companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 2% volume in PA
$18,726 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,186
Medicare services
Top 2% in PA for student in an organized health care education/training program
1,681
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~442 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,650 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
830 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $99 | $287 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
279 | $67 | $207 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
211 | $9 | $112 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
173 | $51 | $136 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $120 | $393 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $135 | $825 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
88 | $8 | $12 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
73 | $74 | $263 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
67 | $64 | $446 |
| Simple change of bladder tube | 33 | $79 | $261 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
30 | $24 | $414 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $85 | $262 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
22 | $29 | $104 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
21 | $20 | $234 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
19 | $126 | $596 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $102 | $559 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
13 | $8 | $183 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
13 | $65 | $232 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $148 | $390 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
4.8% medium
94.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,726
Total received (2018-2024)
Avg $2,675/year across 7 years
Top 2% in PA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
342
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,284 (60.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,442 (39.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,964
2023
$1,946
2022
$5,256
2021
$1,756
2020
$812
2019
$4,879
2018
$114
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$1,298
Medtronic, Inc.
$636
Teleflex LLC
$246
Dendreon Pharmaceuticals LLC
$216
Bayer Healthcare Pharmaceuticals Inc.
$152
PFIZER INC.
$149
Sumitomo Pharma America, Inc.
$148
Janssen Scientific Affairs, LLC
$143
Astellas Pharma US Inc
$128
Janssen Biotech, Inc.
$120
Antares Pharma, Inc.
$113
BLUEWIND MEDICAL
$95
BIOPROTECT MEDICAL, INC.
$87
Merck Sharp & Dohme LLC
$64
SUN PHARMACEUTICAL INDUSTRIES INC.
$63
Tolmar, Inc.
$56
Axonics, Inc.
$42
ABBVIE INC.
$40
UROGEN PHARMA, INC.
$38
Endo USA, Inc.
$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Boston Scientific Corporation
$20
AstraZeneca Pharmaceuticals LP
$19
Ferring Pharmaceuticals Inc.
$19
Mission Pharmacal Company
$17
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$6,146
Intuitive Surgical, Inc.
$3,271
Teleflex LLC
$1,326
INTUITIVE SURGICAL, INC.
$1,298
Dendreon Pharmaceuticals LLC
$1,046
PFIZER INC.
$496
Janssen Biotech, Inc.
$478
Astellas Pharma US Inc
$396
Medtronic USA, Inc.
$326
Bayer HealthCare Pharmaceuticals Inc.
$295
Boston Scientific Corporation
$244
Ferring Pharmaceuticals Inc.
$211
Bayer Healthcare Pharmaceuticals Inc.
$189
PROCEPT BioRobotics Corporation
$181
Sumitomo Pharma America, Inc.
$172
C. R. BARD, INC. & SUBSIDIARIES
$169
Axonics, Inc.
$166
Endo Pharmaceuticals Inc.
$151
Janssen Scientific Affairs, LLC
$143
Blue Earth Diagnostics Limited
$126
BOSTON SCIENTIFIC CORPORATION
$117
Coloplast Corp
$115
Antares Pharma, Inc.
$113
BLUEWIND MEDICAL
$95
Merck Sharp & Dohme LLC
$91
BIOPROTECT MEDICAL, INC.
$87
Amgen Inc.
$82
SUN PHARMACEUTICAL INDUSTRIES INC.
$81
ABBVIE INC.
$81
Acerus Pharmaceuticals Corporation
$67
Tolmar, Inc.
$56
COLOPLAST CORP
$55
Aytu BioScience, Inc
$55
AstraZeneca Pharmaceuticals LP
$50
Foundation Medicine, Inc.
$48
NeoTract Inc.
$47
Supernus Pharmaceuticals, Inc.
$46
C. R. Bard, Inc. & Subsidiaries
$43
Olympus America Inc.
$39
Avadel Specialty Pharmaceuticals, LLC
$38
UROGEN PHARMA, INC.
$38
AbbVie, Inc.
$35
Endo USA, Inc.
$35
Verity Pharmaceuticals Inc.
$34
TOLMAR Pharmaceuticals, Inc.
$33
Clarus Therapeutics Inc.
$32
Zyla Life Sciences, Inc.
$30
Ambu Inc.
$29
Mission Pharmacal Company
$29
Merck Sharp & Dohme Corporation
$29
AbbVie Inc.
$26
Telix Pharmaceuticals
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
ACCORD HEALTHCARE, INC.
$20
ROCHESTER MEDICAL CORPORATION
$19
Accord Healthcare, Inc.
$19
Allergan, Inc.
$17
UROVANT SCIENCES INC
$13
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 57.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AKEEGA · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CONTINENCE CARE · Contour VL · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL ONCOLOGY · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · ILLUCCIX · IMFINZI · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Odomzo · PREMARIN · PROVENGE · Prolia · REVI · ReTrace · Rezum Generator · SPEEDICATH · SPRIX · SpeediCath · TLANDO · Trelstar · URIBEL TABS · UROLIFT · Uribel · UroLift · UroLift System · XIAFLEX · XIFAXAN · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for student in an organized health care education/training program in PA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
991
Per 100K population
115.1
County median income
$111,521
Nearest hospital
POTTSTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA), with low-engagement industry engagement in the top 2% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Lee performed 3,650 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $18,726 from 59 companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other student in an organized health care education/training programs in Pottstown?
Dr. Lee's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Pottstown
Browse student in an organized health care education/training programs in Pottstown ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in PA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in PA
Which PA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology